Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 1997; Volume 25,Issue 9

Articles

  • You have access
    In Vitro Mechanisms of Probenecid-Associated Alterations in Acetaminophen Glucuronide Hepatic Disposition
    Kenneth C. Turner and Kim L. R. Brouwer
    Drug Metabolism and Disposition September 1997, 25 (9) 1017-1021;
  • You have access
    Hepatic Microsomal Metabolism of Montelukast, a Potent Leukotriene D4 Receptor Antagonist, in Humans
    Masato Chiba, Xin Xu, Joy A. Nishime, Suresh K. Balani and Jiunn H. Lin
    Drug Metabolism and Disposition September 1997, 25 (9) 1022-1031;
  • You have access
    Improving the In Vivo Duration of 5-Lipoxygenase Inhibitors
    Jennifer J. Bouska, Randy L. Bell, Carole L. Goodfellow, Andrew O. Stewart, Clint D. W. Brooks and George W. Carter
    Drug Metabolism and Disposition September 1997, 25 (9) 1032-1038;
  • You have access
    Immunological Response to Repeated Administration of Recombinant Human Erythropoietin in Rats
    Motohiro Kato, Kumi Miura, Hiroshi Kamiyama, Akira Okazaki, Kenji Kumaki, Yukio Kato and Yuichi Sugiyama
    Drug Metabolism and Disposition September 1997, 25 (9) 1039-1044;
  • You have access
    Absorption, Distribution, and Elimination of Tea Polyphenols in Rats
    Laishun Chen, Mao-Jung Lee, He Li and Chung S. Yang
    Drug Metabolism and Disposition September 1997, 25 (9) 1045-1050;
  • You have access
    Tissue Distribution Kinetics of a New Nonsteroidal 5α-Reductase Inhibitor, 4-[3-[3-[Bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol1-yl]-butyric Acid, in Rats
    Masataka Katashima, Koujirou Yamamoto, Kaori Haraguchi, Yoji Tokuma, Takehisa Hata, Yasufumi Sawada and Tatsuji Iga
    Drug Metabolism and Disposition September 1997, 25 (9) 1051-1058;
  • You have access
    Oxidation of Methamphetamine and Methylenedioxymethamphetamine by CYP2D6
    L. Y. Lin, E. W. Di Stefano, D. A. Schmitz, L. Hsu, S. W. Ellis, M. S. Lennard, G. T. Tucker and A. K. Cho
    Drug Metabolism and Disposition September 1997, 25 (9) 1059-1064;
  • You have access
    Sex-Dependent Differences in the Disposition of 2,4-Dichlorophenoxyacetic Acid in Sprague-Dawley Rats, B6C3F1 Mice, and Syrian Hamsters
    Robert J. Griffin, Veronica B. Godfrey, Young-Chul Kim and Leo T. Burka
    Drug Metabolism and Disposition September 1997, 25 (9) 1065-1071;
  • You have access
    Fentanyl Metabolism by Human Hepatic and Intestinal Cytochrome P450 3A4: Implications for Interindividual Variability in Disposition, Efficacy, and Drug Interactions
    Rita B. Labroo, Mary F. Paine, Kenneth E. Thummel and Evan D. Kharasch
    Drug Metabolism and Disposition September 1997, 25 (9) 1072-1080;
  • You have access
    Renal Clearance of Ifosfamide
    James Springate, Marianna J. Zamlauski-Tucker, Hong Lu and Kenneth K. Chan
    Drug Metabolism and Disposition September 1997, 25 (9) 1081-1082;
  • You have access
    Absorption and Metabolism of the Absorption Enhancer Didecanoylphosphatidylcholine in Rabbit Nasal Epithelium In Vivo
    Charlotte Vermehren, Peter B. Johansen and Harald S. Hansen
    Drug Metabolism and Disposition September 1997, 25 (9) 1083-1088;
  • You have access
    Human Liver Carboxylesterase hCE-1: Binding Specificity for Cocaine, Heroin, and their Metabolites and Analogs
    Monica R. Brzezinski, Benjamin J. Spink, Robert A. Dean, Clifford E. Berkman, John R. Cashman and William F. Bosron
    Drug Metabolism and Disposition September 1997, 25 (9) 1089-1096;

Short Communications

  • You have access
    [O-ETHYL 14C]PHENACETINO-DEETHYLASE ACTIVITY IN HUMAN LIVER MICROSOMES
    A. David Rodrigues, Bruce W. Surber, Ye Yao, Shekman L. Wong and Ellen M. Roberts
    Drug Metabolism and Disposition September 1997, 25 (9) 1097-1100;
  • You have access
    Metabolic Disposition of the New Fluoroquinolone Antibacterial Agent DW116 in Rats
    Y. H. Park, B. H. Jung, B. C. Chung, J. Park and C. Mitoma
    Drug Metabolism and Disposition September 1997, 25 (9) 1101-1103;
  • You have access
    Evaluation of the Effect of Fluconazole on the Pharmacokinetics of Ritonavir
    Allen Cato, Guoliang Cao, Ann Hsu, John Cavanaugh, John Leonard and Richard Granneman
    Drug Metabolism and Disposition September 1997, 25 (9) 1104-1106;

Letters

  • You have access
    In Vivo Assessment of Intestinal Drug Metabolism
    Jiunn H. Lin, Masato Chiba and Thomas A. Baillie
    Drug Metabolism and Disposition September 1997, 25 (9) 1107-1109;
  • You have access
    Reply
    Norbert Holtbecker, Martin F. Fromm, Heyo K. Kroemer, Edgar E. Ohnhaus and Hugo Heidemann
    Drug Metabolism and Disposition September 1997, 25 (9) 1110-1111;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 9
1 Sep 1997
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Short Communications
  • Letters
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Alternative P450 Splicing Redirects Human Drug Metabolism
  • Switch from CAR to PXR in the Presence of EGF
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics